Biotricity, الرعاية الصحية

Biotricity partners with a second top group purchasing organization – positions company for expanded market access to 1 out of every 2 hospitals in America

Biotricity Inc. (“Biotricity”) today announced its partnership with another of the nation’s top Group Purchasing Organizations (GPOs). This strategic move solidifies Biotricity’s presence in the healthcare landscape and broadly expands market access for the Company in 2024. Biotricity now has access to over half the hospitals in the US, with a network of over 3,000 hospitals, through these two major GPOs which are responsible for over US $160 billion in purchasing power.


Read More

Biotricity, الرعاية الصحية

Biotricity receives Health Canada clearance for Biotres

Biotricity Inc. (“Biotricityy”) announced its Health Canada approval for expansion into the US$1.56 billion Canadian Cardiology Devices market. Cardiovascular disease imposes a staggering US$21.2 billion annual cost in Canada alone, accounting for 11.6% of the entire Canadian health care cost.  Health Canada’s approval of Biotres, Biotricity’s flagship product, is a critical step in the Company’s quest to address the needs of more than 2.4 million Canadians living with heart disease and related conditions. This milestone achievement underscores Biotricity’s dedication to reshaping healthcare through innovation.


Read More

Biotricity, الرعاية الصحية

Biotricity releases another groundbreaking product: Biotres Pro

Biotricity Inc. (Biotricity) today announced their expansion of the current Biotres product platform. The new product, known as Biotres Pro, adds cellular backup for offline connectivity in addition to the existing unique feature set. Biotres has been a game-changing product to the cardiac health market since its release. Biotres Pro continues this trend and establishes Biotricity’s product portfolio as the most comprehensive remote cardiac monitoring product portfolio globally.


Read More

Biotricity, الرعاية الصحية

Biotricity continues to expand patent portfolio with latest patent filing for Bioheart device

Biotricity Inc. (Biotricity) today announced its patent filing for the company’s Bioheart device. Bioheart, regarded as one of the most innovative wearable heart monitoring solutions and recognized as one of TIME Magazine’s Best Inventions of 2022 stands as a “game changer” in the industries of personal heart and remote lifestyle monitoring. This patent safeguards Bioheart’s exclusive 3-view dry-contact technology, advanced sensor system, unique design, and compact form factor, a combination that’s never been seen in the consumer market.


Read More

Biotricity, الرعاية الصحية

Biotricity announces patent filing for cutting-edge Biotres device

Biotricity Inc. (Biotricity) today announced the filing of a patent application for its groundbreaking Biotres device. This patent protects Biotres’ proprietary 3 channel technology, multiple sensors, architecture and compact form factor, a combination that has never been done before.  This filing expands the Company’s IP portfolio while increasing market barriers.


Read More

Biotricity, الرعاية الصحية

Biotricity unveils a new digital presence, highlighting its expanding technology portfolio and cutting-edge innovations

Biotricity Inc. (Biotricity)announced today the official launch a new digital presence that illustrates more completely the depth of Biotricity technologies and solutions.  The company has built a suite of solutions that combine connectivity, smart analytics, AI and cutting-edge cloud technologies. The solutions support individuals and patients from diagnostics to disease management depending on the solution utilized.


Read More

Biotricity, الرعاية الصحية, News

Biotricity expands its proprietary AI model and deepens relationship with Amazon AWS and Google’s tensor flow for remote cardiac care applications

Biotricity Inc. (Biotricity) today announced its strengthened relationships with Amazon and Google. The Company is expanding its AI technology development in remote cardiac care, leveraging its proprietary AI technology to provide a suite of predictive monitoring tools to enhance new disease profiling, improve patient management, and revolutionize the healthcare industry for disease prevention.


Read More

الرعاية الصحية, News

Seaspring signs definitive agreement for joint venture with Asep Inc. for regulatory approval and commercialisation of sepsis diagnosis technology in Bahrain and MENA

Pursuant to the signing of a Letter of Intent (LOI) in December 2022, Seaspring W.L.L. (“Seaspring”) and Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) have signed a definitive agreement (“agreement”) for a joint venture to advance regulatory approval and commercialization of the Company’s sepsis diagnosis technology (SepsetER TM) in the Kingdom of Bahrain and the Middle East and North Africa (MENA).  The terms of the definitive agreement include the formation of a 50/50 joint venture (name to be determined) whereby Seaspring will contribute the capital required (a near-term estimate of USD $5 million that is open-ended
and subject to change) by the joint venture to conduct its business operations (regulatory approval, sales and distribution) and Asep Inc. through its subsidiary Sepset Biosciences Inc., will provide the licensing rights for the use of the SepsetER technology in the Kingdom of Bahrain, Algeria, Egypt, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Qatar, Saudi Arabia, Syria, Tunisia, United Arab Emirates and Yemen.


Read More

Biotricity, الرعاية الصحية

Biotricity releases first corporate impact report

Biotricity Inc. (Biotricity) has released its first has released its first Corporate Impact Report– revealing that the company’s remote, clinical-grade diagnostic devices are inducing “better patient outcomes and substantial cost savings” across the nation.  Presenting new data, the report highlights specific examples of Biotricity’s impact on “reforming the healthcare market by bridging the gap between effective remote diagnostics, remote patient monitoring and chronic care management.”


Read More

Biotricity, الرعاية الصحية

Biotricity signs distribution agreement with top 5 distributor for its Cardiac Monitoring Solutions

Biotricity Inc. (Biotricity) has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists’ patient use – Bioflux® and BiotresTM.  The distribution agreement covers Bioflux and Biotres and will be distributed directly to hospitals and clinics for professional medical utilization with suitable patients.


Read More

1 2 3
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
موقع YouTube
Consent to display content from - Youtube
فيميو
Consent to display content from - Vimeo
خرائط جوجل
Consent to display content from - Google
سبوتيفي
Consent to display content from - Spotify
Sound Cloud
Consent to display content from - Sound